NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save this grant
Crystal ball icon
Predicted Deadline
The next cycle for this opportunity is predicted based on past data. If you save this grant, we’ll notify you if there are any changes.

Next predicted deadline: Dec 7, 2023 (Letter of inquiry)

Later predicted deadlines: Jan 6, 2024 (Letter of inquiry), Jan 7, 2024 (Full proposal), Feb 6, 2024 (Full proposal), Apr 7, 2024 (Letter of inquiry), May 7, 2024 (Full proposal)

Grant amount: Up to US $399,999

Fields of work: Dental Health

Applicant type: Organizations

Funding uses: Research

Location of project: United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico Show all

Location of residency: United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico Show all

Overview:

NOTE: All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates: February 07, 2023, June 06, 2023, October 03, 2023, February 06, 2024, by 5:00 PM local time of the applicant organization. All types of AIDS and AIDS-related applicants allowed for this funding opportunity announcement are due on these dates: January 07, 2023, May 07, 2023, September 07, 2023, January 07, 2024, May 07, 2024, by 5:00 PM local time of the applicant organization.

The purpose of this Funding Opportunity Announcement (FOA) is to seek UG3/UH3 phased cooperative agreement research applications to plan and implement clinical trials within the mission of NIDCR. Awards made under this FOA will initially support a one-year milestone-driven planning phase (UG3), with possible transition to a clinical trial implementation phase of up to five years (UH3). Only UG3 projects that have met the scientific milestones and feasibility requirements may transition to the UH3 phase. The UG3/UH3 application must be submitted as a single application, following the instructions described in this FOA. The UH3 phase of the award will support the conduct of one investigator-initiated clinical trial.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Funding Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

Forecasted Funding Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih) help icon

This page was last reviewed May 09, 2023 and last updated May 09, 2023